Orchestra BioMed (OBIO) vs SNDL (SNDL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Orchestra BioMed (OBIO) has outperformed SNDL (SNDL) over the past year, gaining 97.6% versus a loss of 53.6%. Over five years, OBIO leads with a -41.8% price change compared with -81.4% for SNDL. Orchestra BioMed is the larger company by market cap ($344.4 million vs $300.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OBIO | SNDL |
|---|---|---|
| Share price | $5.73 | $1.22 |
| Market cap | $344.40M | $300.27M |
| 1-day change | +1.24% | -2.40% |
| YTD return | +38.07% | -26.51% |
| 1-year return | +97.59% | -53.61% |
| 5-year return | -41.83% | -81.40% |
| Forward P/E | — | 40.67 |
| EPS (TTM) | $-0.86 | $-0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.50 | $2.84 |
| 52-week low | $2.86 | $1.17 |
| Distance from 52-week high | -11.85% | -57.04% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +116.93% | +184.43% |
| Average volume | 299.84K | 1.52M |
| Shares outstanding | 60.11M | 246.12M |
| Employees | 86 | 2,751 |
| Sector | Healthcare | Consumer Defensive |
| Industry | Biotechnology | Beverages - Wineries & Distilleries |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- OBIO has outperformed SNDL by 151.2 percentage points over the past year.
- The two companies sit in different sectors: Orchestra BioMed in Healthcare and SNDL in Consumer Defensive.
About Orchestra BioMed
OBIO stock →Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Healthcare · Biotechnology · 86 employees
About SNDL
SNDL stock →SNDL Inc. engages in the production, distribution, and sale of cannabis products for the adult-use market in Canada and internationally.
Consumer Defensive · Beverages - Wineries & Distilleries · 2,751 employees
OBIO vs SNDL FAQ
Which is bigger, Orchestra BioMed or SNDL?
Orchestra BioMed (OBIO) is larger, with a market capitalization of $344.40M compared with $300.27M for SNDL (SNDL).
Which stock has performed better over the past year, OBIO or SNDL?
OBIO returned +97.59% over the past 12 months, compared with -53.61% for SNDL (price return, excluding dividends). Past performance does not predict future results.
Are Orchestra BioMed and SNDL in the same industry?
No. Orchestra BioMed is in the Healthcare sector, while SNDL is in Consumer Defensive.